Catalyst Wire Dossier Catalyst Wire Dossier

Ratioepo

epoetin theta · Ratiopharm GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ratioepo, covering 2010-03-22 to 2010-03-22. Get the full timeline:

Most recent: EMA Application withdrawn: Ratioepo (epoetin theta) — Ratiopharm GmbH

See pricing